Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact. [electronic resource]
Producer: 20110725Description: 431-40 p. digitalISSN:- 1557-9042
- Age Factors
- Analysis of Variance
- Animals
- Astrocytes -- drug effects
- Blood-Brain Barrier -- drug effects
- Brain Edema -- drug therapy
- Brain Injuries -- drug therapy
- Cerebral Cortex -- drug effects
- Cognition -- drug effects
- Glial Fibrillary Acidic Protein -- metabolism
- Immunohistochemistry
- Male
- Maze Learning -- drug effects
- Motor Activity -- drug effects
- Niacinamide -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Recovery of Function -- drug effects
- Vitamin B Complex -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.